https://scholars.lib.ntu.edu.tw/handle/123456789/584389
標題: | Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid | 作者: | LING-YING WEI SANG-HENG KOK Lee, Yen-Ching WEI-YIH CHIU Wang, Jai-Jen SHIH-JUNG CHENG Chang, Hao-Hueng JANG-JAER LEE |
關鍵字: | Bone metastasis; Cancer; Medication-related osteonecrosis of the jaws (MRONJ); Prognosis; Zoledronic acid | 公開日期: | 八月-2021 | 卷: | 120 | 期: | 8 | 來源出版物: | Journal of the Formosan Medical Association = Taiwan yi zhi | 摘要: | Anti-resorptive agents are commonly used in cancer patients with bone metastasis or multiple myeloma (MM). An adverse event termed medication-related osteonecrosis of the jaws (MRONJ) was discovered in patients using these agents but relatively little attention has been paid to its prognosis. Our aims were to find out the treatment outcomes and prognostic indicators of MRONJ in cancer patients who received zoledronic acid as antiresorptive therapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/584389 | ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2020.11.017 | SDG/關鍵字: | amoxicillin; amoxicillin plus clavulanic acid; analgesic agent; biological marker; carboxy terminal telopeptide; chlorhexidine; clindamycin; collagen type 1; mouthwash; zoledronic acid; bisphosphonic acid derivative; bone density conservation agent; zoledronic acid; adult; aged; alcohol abstinence; anemia; Article; bone metastasis; bone resection; bone turnover; breast cancer; cancer patient; cancer staging; chronic disease; clinical evaluation; cohort analysis; cone beam computed tomography; conservative treatment; debridement; demography; diabetes mellitus; female; follow up; human; jaw osteonecrosis; major clinical study; male; mandible; maxilla; medication related osteonecrosis of the jaw; multiple myeloma; periimplantitis; periodontitis; prescription; prognosis; prostate cancer; questionnaire; radiodiagnosis; retrospective study; sequestrectomy; smoking cessation; surgery; tooth extraction; tooth implantation; treatment duration; treatment outcome; treatment response; bone necrosis; bone tumor; jaw; jaw osteonecrosis; prognosis; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Jaw; Male; Osteonecrosis; Prognosis; Retrospective Studies; Zoledronic Acid |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。